Array Biopharma Inc. drugs

2 results
  • braftovi - encorafenib capsule

    (Encorafenib)
    Array Biopharma Inc.
    Braftovi treats unresectable or metastatic melanoma (BRAF V600E/V600K), metastatic colorectal cancer (BRAF V600E), and metastatic non-small cell lung cancer (BRAF V600E) in adults. Used in combination with binimetinib or cetuximab. Requires FDA-authorized BRAF mutation testing.
  • mektovi - binimetinib tablet, film coated

    (Binimetinib)
    Array Biopharma Inc.
    Mektovi (binimetinib) is used with encorafenib to treat unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as confirmed by an FDA-approved test.